| Event Details | The 3rd Annual Conference on Arteriosclerosis, Thrombosis and Vascular Biology will be held April 6-8, 2002 in Salt Lake City, Utah.
Investigators working in areas of arteriosclerosis, thrombosis and vascular biology are invited to submit an abstract(s). Abstracts will be selected for oral or poster presentation.
Abstracts may now be submitted electronically. Beginning September 11, 2001, you can visit the AHA ATVB Conference Web site at
to submit your abstract.
The deadline for submission of abstracts is 12:00 midnight EDT, Friday, October 26, 2001. Abstracts received after that date will not be considered
for presentation.
Abstracts may be submitted under the following categories:
* Risk Factors of Coronary Artery Disease -
Obesity/Diabetes
* Mechanisms of Atherosclerosis
* Lipids and Lipoprotein Metabolism
* Macrophage Biology
* Oxidants/Antioxidants
* Platelet Biology and Signaling
* Coagulation Factors and Control Mechanisms
* Fibrinogen Assembly and Fibrinolysis
* Thrombosis, Clinical and Laboratory
* Vascular Proliferation and Remodeling
* Angiogenesis, Vascular Development and
Differentiation
* Cell-cell and Cell-matrix Interactions
* Leukocyte-Endothelial Interactions and Inflammation
* Vascular Cell Signaling and Gene Expression
* Functional Genomics, Proteomics, and Phenotypic
Profiling
* Gene Therapy
All abstracts selected for presentation will be published in the Arteriosclerosis, Thrombosis and Vascular Biology online journal of the American Heart Association. Abstracts accepted for publication may not be
published or presented in any national meeting or world congress in the United States before the conference.
The North American Vascular Biology Organization (NAVBO) will host a workshop on Friday, April 5. Abstracts submitted in the following categories will be considered for presentation during the workshop, and for presentation during the conference poster sessions on Saturday and Sunday evening. The categories are: nuclear receptors, stem cells, and tissue engineering.
Notification of abstract acceptance status will be posted on the AHA Arteriosclerosis, Thrombosis and Vascular Biology Web site after December 17, 2001. Submitters may access the above Web site after that date to
retrieve the information. (Letters to abstract submitters will follow.) |
